Hodgkin-limfóma: vizsgálatok itt: Olaszország

In Olaszország 28 Also abroad 155

28 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Where
Brescia, Meldola, Milan, Naples, Rozzano
Életkor
18 év and over
People
130 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00
1/2. fázisTaking people
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Where
Candiolo, Milan, Naples, Reggio Emilia, Rome, Rozzano
Életkor
18 év and over
People
280 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00
1/2. fázisTaking people
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Where
Rome, Turin
Életkor
Up to 17 év
People
37 worldwide
Run by
F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 · EU 2023-504264-41-00
1. fázisTaking people
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Where
Bologna, Milan
Életkor
18 év and over
People
460 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00
1. fázisTaking people
A Study of ARC-02 in B-cell NHL
Where
Aviano, Bergamo, Bologna, Rozzano
Életkor
18 év and over
People
140 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00
1/2. fázisTaking people
A Phase 1/2a Study of UCART20x22 in B-Cell Non-Hodgkin Lymphoma [NatHaLi-01]
Where
Milan
Életkor
18 év and over
People
48 worldwide
Run by
Cellectis
See details and how to joinNCT05607420 · EU 2022-501607-27-00
1. fázisTaking people
An early Phase 1b Study to assess how safe and effective is the treatment with drugs, called Mosunetuzumab or Glofitamab in Combination with drugs called, CC-220 and CC-99282 in Patients with B-Cell Non-Hodgkin Lymphoma.
Where
Bologna, Brescia, Meldola, Milan, Pisa
Életkor
18 év and over
People
52 worldwide
Run by
F. Hoffmann-La Roche AG
See details and how to join2023-505185-28-00 · EU 2023-505185-28-00
1. fázisNot yet taking people in Olaszország
A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma
Where
Bergamo, Bologna, Candiolo, Turin
Életkor
18 év and over
People
34 worldwide
Run by
Kyowa Kirin Inc.
See details and how to joinNCT07192471 · EU 2025-522523-96-00
2. fázisTaking people
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Where
Alexandria, Bologna, Busto Arsizio, Milan
Életkor
18 év and over
People
270 worldwide
Run by
AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00
1/2. fázisTaking people
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Where
Alessandria, Bologna, Milan
Életkor
12 év and over
People
161 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00
3. fázisTaking people
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Where
Meldola, Ravenna, Rome, Tricase
Életkor
18 év and over
People
49 worldwide
Run by
Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00
2. fázisTaking people
Phase II study: efficacy and safety of tislelizumab in patients with de novo Hodgkin lymphoma unsuitable for standard chemotherapy
Where
Alexandria, Aviano, Bologna, Brescia, Milan, Naples, Novara, Palermo, Reggio Emilia, Rome, Rozzano
Életkor
65 év and over
People
25
Run by
Fondazione Italiana Linfomi Onlus
See details and how to join2022-503090-11-00 · EU 2022-503090-11-00
3. fázisTaking people
Randomized study to protect from radiation iatrogenic hypothyroidism patients with medulloblastoma (any stage, any biological risk) and pediatric patients with Hodgkin lymphoma and non-Hodgkin lymphoma needing radiation therapy on thyroid site - WINHYPO 2021
Where
Milan
People
65
Run by
Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2024-512642-42-00 · EU 2024-512642-42-00
1/2. fázisTaking people
A study to evaluate safety and clinical activity of GSK5926371 in adult participants with relapsed or refractory B-NHL
Where
Alexandria, Milan, Rozzano
Életkor
18 év and over
People
30 worldwide
Run by
Glaxosmithkline Research & Development Limited
See details and how to join2025-524915-36-00 · EU 2025-524915-36-00
1. fázisTaking people
A Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
Where
Bergamo, Bologna, Brescia, Milan
Életkor
18 év and over
People
121 worldwide
Run by
ADC Therapeutics SA
See details and how to joinNCT04970901 · EU 2024-512089-32-00
3. fázisTaking people
PET Guided Dose Reduction for InvOlved Site Radiotherapy In Early sTage Unfavourable Hodgkin Lymphoma
Where
Alessandria, Avellino, Aviano, Bergamo, Brescia, Cagliari, Candiolo, Catania, Cuneo, Florence, Genova, Latina, Milan, Novara, Padova, Palermo, Pavia, Perugia, Piacenza, Ravenna, Reggio Emilia, Roma, Rozzano, San Giovanni Rotondo, Siena, Terni, Torino, Treviso, Trieste, Udine, Verona
Életkor
18 év and over
People
518
Run by
Fondazione Italiana Linfomi - ETS
See details and how to joinNCT07256158
2. fázisTaking people
Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy
Where
Alessandria, Aviano, Bologna, Brescia, Milan, Naples, Novara, Palermo, Reggio Emilia, Roma, Rozzano
Életkor
65 év and over
People
28
Run by
Fondazione Italiana Linfomi - ETS
See details and how to joinNCT05977673
1/2. fázisTaking people
A trial to learn how safe AZD4512 is with and without other cancer drugs and how it works in the bodies of people with B-cell non-Hodgkin lymphoma (B-NHL)
Where
Bologna, Milan
Életkor
18 év and over
People
18
Run by
AstraZeneca AB
See details and how to join2025-522371-29-00 · EU 2025-522371-29-00
1/2. fázisTaking people
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Where
Rome
Életkor
6 hónap to 17 év
People
370 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00
3. fázisTaking people
A trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
Where
Aviano, Brescia, Meldola, Novara, Roma, Siena, Varese
Életkor
18 év and over
People
132 worldwide
Run by
Regeneron Pharmaceuticals Inc.
See details and how to joinNCT06230224 · EU 2022-502783-21-00
2. fázisTaking people
Clinical trial with a combination of Rituximab and Golcadomide as first line therapy for older frail patients with Diffuse Large B-cells non-Hodgkin Lymphoma
Where
Alexandria, Ancona, Avellino, Aviano, Brescia, Florence, Milan, Monza, Padova, Palermo, Pescara, Piacenza, Ravenna, Reggio Emilia, Rome, Siena, Trieste, Turin, Verona
Életkor
65 év and over
People
47
Run by
Fondazione Italiana Linfomi Ets
See details and how to join2023-506206-38-00 · EU 2023-506206-38-00
1. fázisTaking people
Study of SGR-1505 in Mature B-Cell Neoplasms
Where
Alexandria, Milan, Turin, Verona
Életkor
18 év and over
People
98 worldwide
Run by
Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00
No phaseTaking people
Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation.
Where
Bologna
Életkor
18 év to 38 év
People
50
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT07270679
No phaseTaking people
Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines
Where
Bologna
Életkor
18 év and over
People
160
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06774326
No phaseTaking people
Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
Where
Bologna
Életkor
18 év and over
People
40
Run by
IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06733987